Skip to content

Author

Xiao Yu

We have 3 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

AXL drives immunotherapy resistance by modulating IL-17 in bladder cancer.

Given the persistently poor five-year survival rate (<10 %) in metastatic bladder cancer (BLCA) and the limited efficacy of conventional chemotherapy and programmed cell death protein 1 (PD-1) inhibitor monotherapy, there is an urgent need to identify novel immune targets and rational combination strategies. Therefore,...

Wen-Long Wan, Fang Wei, Lu Yang et al. · 0 citations
Open access Sep 2026

Integrative transcriptomic and single-cell analyses identify CD74 as a candidate regulator of ferroptosis in renal tubular cells during nephrolithiasis

Findings support a potential role of CD74-associated NF-κB signaling in ferroptosis-related tubular injury during nephrolithiasis and suggest that the CD74/NF-κB axis may represent a potential therapeutic direction and provide mechanistic insight for future studies.

Jun-Yi Yang, Bao-Feng Wang, Yang Xun et al. · 0 citations
Open access Aug 2026

Exploring the Molecular Mechanisms by Which DEHP Promotes the Occurrence and Progression of Kidney Stones Based on Network Toxicology and Experimental Validation

Findings provide mechanistic evidence linking DEHP exposure to kidney stone pathogenesis by disrupting apoptosis–autophagy homeostasis in renal tubular epithelial cells.

Yongqi Wang, Jian-Qiao Pu, Yang Xun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.